Noguera Hernando E, Larrea Gayarre A, Cruz Martínez J, Rossi Raviolo I
Allergol Immunopathol (Madr). 1976 Nov-Dec;4(6):409-12.
Australian antigen (Au Ag) was first described by Blumberg in the serum of an Australian aborigen. Its main clinical significance is based on the fact of its association with the presence of hepatitis B (Okochi, Nurakami, 1968; Prince, 1968) (9). Almeida (1969) outlines the intervention of immune complexes on the production of the referred illness. Later works show the importance of the type of immunologic response created by Au Ag (2). Alpert et al. (1) (1970) state the possibility that immune complexes developed by Au Ag and anti Au Ag antibodies may produce in patients with hepatitis B other allied manifestations including arthritis. On the basis of similar immunopathological findings (illnesses including immunocomplexes on their production), Au Ag investigation in rheumatoid arthritis (RA) has been the object of several works, whose results reveal certain discrepancies. We have investigated the presence of Au Ag on 70 patients whose diagnostic was RA "classical (according to the judgement of the American Rheumatism Association). We used immunoelectrophoresis (counter immunoelectrophoresis-CIEP-) and radioimmunoassay (RIA) techniques. We prepared individual records including clinical, epidemic, biochemical and personal data. Au Ag investigation both through different techniques gave negative results in 70 cases, of which only four referred a possible previous hepatitis B clinic history, not showing during the investigation suggestive clinical data of hepatitis or biochemical alterations. Panus et al. (1970) (5), Desche-Labarte et al. (1972), Trempo (1972), Burrel (1973) (6), Serré et al. (1973) (8), obtained negative results in the matter, with similar or lower casuistics than ours. Notwithstanding Roqués et al. (1975) (7), in 300 cases of RA showed the presence of Au Ag in a significant number of cases (5%) as compared to Au Ag incidence in the French population (estimated in about 0.22%) (6). However, Roqués did not find in their Au Ag positive cases any evidence which enables to think that this antigen has played an important role on the origin and development of the rheumatic illness. These important discrepancies may be due to different reasons: a) Use of different techniques for Au Ag detection. b) The transitory character of the presence of Au Ag in the serum. c) Important differences in the antigen geographic distribution. d) Previous hepatitis B. There are som other factors which have attained importance recently, as a consequence of the broad epidemiological studies carried out. So, Au Ag increased incidence has been found--statistically significant--on groups of persons who have been submitted to several surgical interventions and/or have needed repeated hospitalizations or reiterated blood transfusions (6). These three conditions--especially the first two--are accomplished in an illness with chronic and invalidating characteristics as RA...
澳大利亚抗原(Au Ag)最早由布伦伯格在一名澳大利亚原住民的血清中发现。其主要临床意义在于它与乙型肝炎的存在有关(小河内、村上,1968年;普林斯,1968年)(9)。阿尔梅达(1969年)概述了免疫复合物在引发上述疾病中的作用。后来的研究表明了Au Ag引发的免疫反应类型的重要性(2)。阿尔珀特等人(1)(1970年)指出,Au Ag和抗Au Ag抗体形成的免疫复合物可能会在乙型肝炎患者身上引发包括关节炎在内的其他相关症状。基于类似的免疫病理学发现(包括免疫复合物生成在内的疾病),类风湿关节炎(RA)中Au Ag的研究成为多项研究的对象,但其结果存在一定差异。我们对70例被诊断为“典型类风湿关节炎(根据美国风湿病协会的判断)”的患者进行了Au Ag检测。我们使用了免疫电泳(对流免疫电泳 - CIEP)和放射免疫测定(RIA)技术。我们准备了包含临床、流行病学、生化和个人数据的个体记录。通过不同技术进行的Au Ag检测在70例病例中均得出阴性结果,其中只有4例提及可能有既往乙型肝炎临床病史,但在调查期间未显示出提示肝炎的临床数据或生化改变。帕努斯等人(1970年)(5)、德谢 - 拉巴特等人(1972年)、特伦波(1972年)、伯勒尔(1973年)(6)、塞雷等人(1973年)(8)在这方面也得出了阴性结果,病例数与我们的相似或比我们的少。尽管如此,罗克斯等人(1975年)(7)在300例类风湿关节炎病例中发现相当数量的病例(5%)存在Au Ag,相比法国人群中Au Ag的发生率(估计约为0.22%)(6)。然而,罗克斯在其Au Ag阳性病例中未发现任何证据表明该抗原在风湿性疾病的起源和发展中起重要作用。这些重大差异可能归因于不同原因:a)检测Au Ag使用的技术不同。b)血清中Au Ag存在的短暂性。c)抗原地理分布的重大差异。d)既往乙型肝炎。由于广泛开展的流行病学研究,最近还发现了其他一些重要因素。因此,在接受过多次外科手术和/或需要反复住院或多次输血的人群中,Au Ag的发生率显著增加(6)。类风湿关节炎这种具有慢性和致残特征的疾病具备这三种情况,尤其是前两种……